Short-Course Subcutaneous Alemtuzumab Induces Clinical Responses in Relapsed T-Cell Large Granular Leukemia

Authors

Miguel Ruiz
Zachary Braunstein
Eric McLaughlin
Anjali Mishra, Thomas Jefferson UniversityFollow
Pierluigi Porcu, Thomas Jefferson UniversityFollow
Jonathan E. Brammer

Document Type

Article

Publication Date

4-2025

Comments

This article is the author's final published version in Haematologica, Volume 110, April 2025, Issue 4, Pages 995-998.

The published version is available at https://doi.org/10.3324/haematol.2024.286235. Copyright © 2025 Ferrata Storti Foundation.

Recommended Citation

Ruiz, Miguel; Braunstein, Zachary; McLaughlin, Eric; Mishra, Anjali; Porcu, Pierluigi; and Brammer, Jonathan E., "Short-Course Subcutaneous Alemtuzumab Induces Clinical Responses in Relapsed T-Cell Large Granular Leukemia" (2025). Department of Medical Oncology Faculty Papers. Paper 291.
https://jdc.jefferson.edu/medoncfp/291

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

PubMed ID

39540224

Language

English